skip to Main Content

MaRS Innovation launches streamlined funding program

Applications invited for MI’s Industry Access Program, which matches early-stage, high-potential technologies to partners and funding

The commercialization process: Moving transformational ideas from the lab bench to the street
MaRS Innovation’s commercialization process helps inventors move their transformational ideas from the lab bench to the street.

MaRS Innovation (MI) has launched a unique funding program to match researchers with industry partners while advancing early stage technologies: the MaRS Innovation Industry Access Program (MI-IAP).

This program provides a simple mechanism to connect researchers with MI’s industry partners. The process and application form are intentionally brief to save researchers time and allow MI’s partners to review a wide range of remarkable technologies within the Toronto academic community in a short period of time.

ParimalNathwani8757
Parimal Nathwani, vice-president, Life Sciences,     MaRS Innovation.

“Many granting programs require an industry partner, but leave finding that partner to the researcher,” says Parimal Nathwani, vice-president of life sciences at MI. “Our Industrial Partnership Program completes that step for them. We also know researchers within our member institutions are incredibly busy, which is why we’ve adopted a streamlined process to save them time.”

The program is open to any researcher affiliated with our 16 member institutions working on technologies in:

  • therapeutics
  • diagnostics
  • medical devices
  • health IT
Continue Reading

Baxter et MaRS Innovation forment un partenariat stratégique

Un partenariat visant à investir jusqu’à 1 M$ dans les découvertes canadiennes prometteuses en matière de soins de santé

Baxter Corporate Headquarters in Mississauga, ON
Baxter Corporate Headquarters in Mississauga, ON

TORONTO (Ontario), le 4 octobre 2012 – Baxter International Inc. et MaRS Innovation, un centre d’excellence en commercialisation et en recherche, ont établi un partenariat stratégique afin de commercialiser des technologies en phase de développement qui constituent des méthodes novatrices sur le plan des technologies thérapeutiques et de découverte de médicaments.

Information about MaRS Innovation and Baxter’s partnership is also available in English.

Continue Reading
Back To Top